AU2785699A - Method and compositions for differential detection of primary tumor cells and metastatic cells - Google Patents

Method and compositions for differential detection of primary tumor cells and metastatic cells

Info

Publication number
AU2785699A
AU2785699A AU27856/99A AU2785699A AU2785699A AU 2785699 A AU2785699 A AU 2785699A AU 27856/99 A AU27856/99 A AU 27856/99A AU 2785699 A AU2785699 A AU 2785699A AU 2785699 A AU2785699 A AU 2785699A
Authority
AU
Australia
Prior art keywords
cells
compositions
method
primary tumor
differential detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27856/99A
Inventor
Emilio Barbera-Guillem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CLI Oncology Inc
Original Assignee
CLI Oncology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US3204898A priority Critical
Priority to US09032048 priority
Application filed by CLI Oncology Inc filed Critical CLI Oncology Inc
Priority to PCT/US1999/004005 priority patent/WO1999044064A1/en
Publication of AU2785699A publication Critical patent/AU2785699A/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57415Specifically defined cancers of breast
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/5743Specifically defined cancers of skin, e.g. melanoma
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/54Interleukins [IL]
    • G01N2333/55IL-2
AU27856/99A 1998-02-27 1999-02-24 Method and compositions for differential detection of primary tumor cells and metastatic cells Abandoned AU2785699A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US3204898A true 1998-02-27 1998-02-27
US09032048 1998-02-27
PCT/US1999/004005 WO1999044064A1 (en) 1998-02-27 1999-02-24 Method and compositions for differential detection of primary tumor cells and metastatic cells

Publications (1)

Publication Number Publication Date
AU2785699A true AU2785699A (en) 1999-09-15

Family

ID=21862819

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27856/99A Abandoned AU2785699A (en) 1998-02-27 1999-02-24 Method and compositions for differential detection of primary tumor cells and metastatic cells

Country Status (3)

Country Link
AU (1) AU2785699A (en)
CA (1) CA2322282A1 (en)
WO (1) WO1999044064A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6913697B2 (en) 2001-02-14 2005-07-05 Science & Technology Corporation @ Unm Nanostructured separation and analysis devices for biological membranes
EP1409727B1 (en) * 2001-09-06 2005-11-09 Adnagen AG Method for qualitative and/or quantitative detection of cells
DE50209932D1 (en) * 2001-09-06 2007-05-24 Adnagen Gmbh A method and kit for diagnosis or treatment control of colon cancer
WO2003023060A2 (en) * 2001-09-06 2003-03-20 Adnagen Ag Method and kit for diagnosing or controlling the treatment of breast cancer
US7318902B2 (en) 2002-02-04 2008-01-15 Colorado School Of Mines Laminar flow-based separations of colloidal and cellular particles
AT531257T (en) 2002-09-27 2011-11-15 Gen Hospital Corp A microfluidic device for cell separation and uses thereof
US9885644B2 (en) 2006-01-10 2018-02-06 Colorado School Of Mines Dynamic viscoelasticity as a rapid single-cell biomarker
US20070196820A1 (en) 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
EP3424598A1 (en) 2006-06-14 2019-01-09 Verinata Health, Inc Rare cell analysis using sample splitting and dna tags
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
US9878326B2 (en) 2007-09-26 2018-01-30 Colorado School Of Mines Fiber-focused diode-bar optical trapping for microfluidic manipulation
PL2334812T3 (en) 2008-09-20 2017-06-30 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
US9487812B2 (en) 2012-02-17 2016-11-08 Colorado School Of Mines Optical alignment deformation spectroscopy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284412A (en) * 1979-07-13 1981-08-18 Ortho Diagnostics, Inc. Method and apparatus for automated identification and enumeration of specified blood cell subclasses
US4727020A (en) * 1985-02-25 1988-02-23 Becton, Dickinson And Company Method for analysis of subpopulations of blood cells
WO1994020120A1 (en) * 1993-03-12 1994-09-15 Cellcor, Inc. In vitro assay measuring degree of activation of immune cells
US5536642A (en) * 1993-09-09 1996-07-16 Barbera-Guillem; Emilio Diagnostic and prognostic methods for solid non-lymphoid tumors and their metastases

Also Published As

Publication number Publication date
CA2322282A1 (en) 1999-09-02
WO1999044064A1 (en) 1999-09-02

Similar Documents

Publication Publication Date Title
AU769386C (en) Enzymes mixture
GB9903332D0 (en) Method for milling casing and drilling formation
AU2378995A (en) Germline mutations in the MTS gene and method for detecting predisposition to cancer at the MTS gene
PL338990A1 (en) Photovoltaic module and method of making same
AU8124994A (en) Compositions that specifically bind to colorectal cancer cells and methods of using the same
AUPM704594A0 (en) Efficient methods for the compositing of graphical elements
AU2549297A (en) Materials and methods for making improved echogenic liposome compositions
AU4329199A (en) Can bottom having improved strength and apparatus for making same
AU2099799A (en) Optoelectronic assembly and method of making the same
AU2247397A (en) Methods and compositions for determining the sequence of nucleic acid molecules
AU4249600A (en) Insulated wall construction and forms and methods for making same
AU6245699A (en) Method and apparatus for measuring complex impedance of cells and batteries
AU6952798A (en) Hosel coupling assembly and method of using same
AU4677399A (en) Inhibitors of H+K+-ATPase
AU1692797A (en) Mesothelium antigen and methods and kits for targeting it
AU5023000A (en) Paraffin/petrolatum candle and method of forming the same
AU6299898A (en) Method & apparatus for the formation of particles
AU6544598A (en) Compositions and methods for analysis of nucleic acids
AU5220098A (en) Compositions and methods for enhancing intestinal function
AU6976298A (en) Improved urine specimen container and method for using same
AU1502395A (en) Detection of nucleic acid amplification
AU2324997A (en) Detection of extracellular tumor-associated nucleic acid in blood plasma or ser um using nucleic acid amplification assays
AU4759297A (en) Synthesis of aryl ethers, methods and reagents related thereto
AU3298999A (en) System and method for increasing the isolation characteristic of an antenna
AU5641598A (en) Method for determining density of earth formations

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase